Browse U.S. mass tort news by month. Each update links to its source and shows when AMMS verified it.
FDA announced that Pfizer was withdrawing voxelotor, sold as Oxbryta for sickle cell disease. The agency cited postmarketing studies reporting more severe pain crises and deaths in the treatment group than in the placebo group.
Hernia mesh litigation. MDL 2846, docket entry 858.
Camp Lejeune litigation. Camp Lejeune water litigation, docket entry 283.
EPA published this rule in the Federal Register. The original notice is document 2024-19931.
Each campaign page includes its supporting sources, records checklist, FAQs, and review form.
